Whats new
Whats new.
CLSA - 1L Head & Neck Cohort B ORR 5x higher vs Keytruda monotherapy; Response rate encouraging in difficult to treat patients, surprises to the upside (Analyst: Andrew Paine)
April 24th 2024
For a copy of this research report please contact your CLSA advisor